Cargando…
Drug–Drug Interactions Based on Pharmacogenetic Profile between Highly Active Antiretroviral Therapy and Antiblastic Chemotherapy in Cancer Patients with HIV Infection
The introduction of Highly Active Antiretroviral Therapy (HAART) into clinical practice has dramatically changed the natural approach of HIV-related cancers. Several studies have shown that intensive antiblastic chemotherapy (AC) is feasible in HIV-infected patients with cancer, and that the outcome...
Autores principales: | Berretta, Massimiliano, Caraglia, Michele, Martellotta, Ferdinando, Zappavigna, Silvia, Lombardi, Angela, Fierro, Carla, Atripaldi, Luigi, Muto, Tommaso, Valente, Daniela, De Paoli, Paolo, Tirelli, Umberto, Di Francia, Raffaele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4811911/ https://www.ncbi.nlm.nih.gov/pubmed/27065862 http://dx.doi.org/10.3389/fphar.2016.00071 |
Ejemplares similares
-
ANTIBLASTIC IMMUNITY
por: Dochez, A. R., et al.
Publicado: (1916) -
STUDIES ON ANTIBLASTIC IMMUNITY
por: Blake, Francis G.
Publicado: (1917) -
Assessment of Pharmacogenomic Panel Assay for Prediction of Taxane Toxicities: Preliminary Results
por: Di Francia, Raffaele, et al.
Publicado: (2017) -
A new peg-filgrastim biosimilar, mecapegfilgrastim for primary prophylaxis of chemotherapy-related neutropenia is now available
por: Tirelli, Umberto, et al.
Publicado: (2020) -
Metabolomic Perspectives in Antiblastic Cardiotoxicity and Cardioprotection
por: Deidda, Martino, et al.
Publicado: (2019)